EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 376 filers reported holding EXELIXIS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,985,268 | +100.4% | 488,886 | +111.7% | 0.01% | +150.0% |
Q1 2024 | $5,481,132 | -84.6% | 230,979 | -84.4% | 0.00% | -86.7% |
Q4 2023 | $35,581,296 | -6.2% | 1,483,172 | -14.5% | 0.02% | -21.1% |
Q3 2023 | $37,913,421 | +19.2% | 1,735,168 | +4.3% | 0.02% | +18.8% |
Q2 2023 | $31,798,811 | +1039076.8% | 1,663,988 | +955.6% | 0.02% | +700.0% |
Q1 2023 | $3,060 | +116.1% | 157,634 | +78.6% | 0.00% | +100.0% |
Q4 2022 | $1,416 | -100.0% | 88,256 | -93.5% | 0.00% | -91.7% |
Q3 2022 | $21,135,000 | +5.0% | 1,347,879 | +39.5% | 0.01% | 0.0% |
Q2 2022 | $20,123,000 | +115.1% | 966,545 | +134.2% | 0.01% | +140.0% |
Q1 2022 | $9,355,000 | -0.2% | 412,640 | -19.5% | 0.01% | 0.0% |
Q4 2021 | $9,370,000 | +13.8% | 512,609 | +31.6% | 0.01% | 0.0% |
Q3 2021 | $8,232,000 | +50.4% | 389,397 | +29.7% | 0.01% | +66.7% |
Q2 2021 | $5,472,000 | -73.6% | 300,285 | -67.3% | 0.00% | -80.0% |
Q1 2021 | $20,765,000 | +528.5% | 919,186 | +458.3% | 0.02% | +650.0% |
Q4 2020 | $3,304,000 | +129.0% | 164,626 | +178.9% | 0.00% | 0.0% |
Q3 2020 | $1,443,000 | -75.1% | 59,035 | -75.9% | 0.00% | -75.0% |
Q2 2020 | $5,806,000 | -57.0% | 244,572 | -68.8% | 0.01% | -73.3% |
Q1 2020 | $13,518,000 | +12.7% | 785,023 | +15.4% | 0.03% | +100.0% |
Q4 2019 | $11,991,000 | +31.8% | 680,548 | +32.3% | 0.02% | +7.1% |
Q3 2019 | $9,095,000 | +0.1% | 514,319 | +21.0% | 0.01% | 0.0% |
Q2 2019 | $9,083,000 | -36.2% | 425,034 | -29.0% | 0.01% | -36.4% |
Q1 2019 | $14,244,000 | -50.9% | 598,476 | -59.4% | 0.02% | -51.1% |
Q4 2018 | $29,000,000 | -25.7% | 1,474,325 | -33.1% | 0.04% | -6.2% |
Q3 2018 | $39,034,000 | +181.8% | 2,202,840 | +242.2% | 0.05% | +166.7% |
Q2 2018 | $13,854,000 | -39.2% | 643,763 | -37.4% | 0.02% | -40.0% |
Q1 2018 | $22,789,000 | -36.5% | 1,028,870 | -12.8% | 0.03% | -40.0% |
Q4 2017 | $35,866,000 | -12.3% | 1,179,788 | -30.1% | 0.05% | -19.4% |
Q3 2017 | $40,918,000 | -4.1% | 1,688,718 | -2.6% | 0.06% | -18.4% |
Q2 2017 | $42,687,000 | +20.8% | 1,733,104 | +6.3% | 0.08% | +16.9% |
Q1 2017 | $35,327,000 | -19.7% | 1,630,214 | -44.7% | 0.06% | -28.6% |
Q4 2016 | $43,978,000 | +212.0% | 2,949,564 | +167.6% | 0.09% | +295.7% |
Q3 2016 | $14,097,000 | -56.4% | 1,102,160 | -73.4% | 0.02% | -68.9% |
Q2 2016 | $32,327,000 | +3148.9% | 4,139,212 | +1564.2% | 0.07% | +3600.0% |
Q1 2016 | $995,000 | +148.8% | 248,723 | +250.9% | 0.00% | +100.0% |
Q4 2015 | $400,000 | -94.3% | 70,889 | -96.2% | 0.00% | -92.9% |
Q2 2015 | $7,019,000 | +97.9% | 1,866,892 | +35.3% | 0.01% | +133.3% |
Q1 2015 | $3,546,000 | +44.7% | 1,379,692 | -18.9% | 0.01% | +20.0% |
Q4 2014 | $2,450,000 | +22.4% | 1,701,248 | +30.0% | 0.01% | 0.0% |
Q3 2014 | $2,002,000 | -42.3% | 1,308,540 | +27.9% | 0.01% | -50.0% |
Q2 2014 | $3,469,000 | -52.2% | 1,023,300 | -50.0% | 0.01% | -52.4% |
Q1 2014 | $7,251,000 | -16.6% | 2,048,337 | +44.3% | 0.02% | -22.2% |
Q4 2013 | $8,699,000 | +182.1% | 1,419,196 | +167.8% | 0.03% | +170.0% |
Q3 2013 | $3,084,000 | +18.3% | 529,862 | -7.7% | 0.01% | +25.0% |
Q2 2013 | $2,607,000 | – | 574,151 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 19,070,213 | $31,466,000 | 36.51% |
GREAT POINT PARTNERS LLC | 5,100,000 | $7,803,000 | 3.35% |
Rhenman & Partners Asset Management AB | 500,000 | $765,000 | 0.22% |
NEA Management Company, LLC | 2,207,000 | $3,377,000 | 0.17% |
Adamant Biomedical Investments AG | 300,000 | $459,000 | 0.12% |
Cutler Capital Management, LLC | 91,000 | $139,000 | 0.06% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,000,000 | $1,530,000 | 0.06% |
NWAM LLC | 65,916 | $101,000 | 0.04% |
Teton Advisors, Inc. | 200,000 | $306,000 | 0.02% |
SHELTON CAPITAL MANAGEMENT | 100,000 | $153,000 | 0.02% |